Skip to content
Catalyst
Free testosterone

1 finding · 1 compound · 1 null · by evidence strength. No dose is advised.

Fig. 2 Free testosterone1 compound outer ring on requestSelected Free testosterone · centre
×1.60
Labels
Measured outcomeInspector

Free testosterone

Findings drawn, by strength

1finding · 1 compound

  • Moderate1
Keys

← → round a ring↑ ↓ out and inEnter selecte the outer ringf fit to view+ − zoomEsc clearclick a node to select it

Compound no difference foundFindingsStrongest
1
Moderate

Not pooled · no summary effect · point at a mark · Tab, then the arrow keys

Measured, no difference found1 finding

  1. Eurycoma longifoliaMoved: no difference foundEvidence: ModeratePaper: PMID 342624172021An author is affiliated with a producer
    Who
    Ageing men aged 50 to 70 years with baseline total testosterone below 300 ng/dL and BMI 18 to 30 kg/m2; Physta 100 mg and 200 mg arms each compared with placebo, 35 per arm
    Dose studied
    100 mg or 200 mg once daily after breakfast for 12 weeks

    There were no significant between-group differences in the free testosterone levels for Physta® 100 and 200 mg compared to placebo at all-time points.”

    Quoted verbatim from Effect of Eurycoma longifolia standardised aqueous root extract-Physta® on testosterone levels and quality of life in ageing male subjects: a randomised, double-blind, placebo-controlled multicentre study.RCT · 3 monthsPermalink

How it is measured

Concentration of unbound testosterone, the fraction not carried by its binding proteins, in a blood sample drawn at a stated time of day. Accepted methods: equilibrium dialysis or ultrafiltration (the physical separations), or calculation from measured testosterone and its binding-protein concentrations by the Vermeulen or Sodergard equation. A direct analogue immunoassay of free testosterone is not accepted. The method and the draw time are recorded with each finding; a value whose method the source does not state is recorded as unstated.

Measured, with no finding

9 measurements

Show what was measuredHide what was measured
  • Free testosterone

    Free testosterone (ng/dL) | 17.76 ± 10.98 | 35.29 ± 15.01*** | 21.30 ± 12.24 | 31.70 ± 19.48**

    PMID 30356905 · one of two readings recorded this

  • free testosterone

    no effect, p = 0.732

    Free testosterone (pmol/L) | 6.27 ± 5.20 | 6.93 ± 4.48 | 0.360 | 8.73 ± 11.64 | 6.93 ± 3.70 | 0.732 | 6.19 ± 3.94 | 7.03 ± 4.25 | 0.960

    PMID 33061884 · one of two readings recorded this

  • free testosterone

    no effect, p = 0.96

    Free testosterone (pmol/L) | 6.27 ± 5.20 | 6.93 ± 4.48 | 0.360 | 8.73 ± 11.64 | 6.93 ± 3.70 | 0.732 | 6.19 ± 3.94 | 7.03 ± 4.25 | 0.960

    PMID 33061884 · one of two readings recorded this

  • Free testosterone

    no effect, p = 0.99, n = 35

    Free testosterone (pg/ml) | Physta® 100 mg | 16.78 ± 12.53 | >0.99 | 16.98 ± 12.69 | 0.85 | 17.17± 12.70 ## | 0.96 | 17.41 ± 12.77 ### | >0.99 | 17.63 ± 12.73 ### | >0.99

    PMID 34262417 · one of two readings recorded this

  • Free testosterone

    no effect, p = 0.71, n = 35

    Physta® 200 mg | 14.09 ± 10.82 | 0.15 | 15.55 ± 12.43 ## | 0.35 | 15.91± 12.60 ## | 0.50 | 16.25 ± 12.66 ### | 0.69 | 16.47 ± 12.84 ### | 0.71

    PMID 34262417 · one of two readings recorded this

  • Free testosterone

    n = 35

    Placebo | 16.87 ± 14.69 | 17.45 ± 15.47 | 17.39 ± 15.44 | 17.31 ± 15.35 | 17.56 ± 15.71

    PMID 34262417 · one of two readings recorded this

  • Free testosterone

    Baseline | 7.63 ± 2.04 | 7.39 ± 1.82

    PMID 41923399 · one of two readings recorded this

  • Free testosterone

    4 weeks | 9.03 ± 2.76 | 7.13 ± 1.80

    PMID 41923399 · one of two readings recorded this

  • Free testosterone

    8 weeks | 9.29 ± 2.04 | 7.03 ± 1.74

    PMID 41923399 · one of two readings recorded this

Papers about it

As an endpoint5

Show the papersHide the papers
  • Efficacy and Safety of TESTOPEAK™ in Improving Symptoms of Andropause in Korean Men: An 8-Week, Single-Center, Randomized, Parallel-Group, Placebo-Controlled Trial.

    American journal of men's health2026PMID 41923399Via: named in the paper, as read

  • Effect of Eurycoma longifolia standardised aqueous root extract-Physta® on testosterone levels and quality of life in ageing male subjects: a randomised, double-blind, placebo-controlled multicentre study.

    Food & nutrition research2021PMID 34262417Via: named in the paper, as read

  • Efficacy of Labisia pumila and Eurycoma longifolia standardised extracts on hot flushes, quality of life, hormone and lipid profile of peri-menopausal and menopausal women: a randomised, placebo-controlled study.

    Food & nutrition research2020PMID 33061884Via: named in the paper, as read

  • Beneficial effects of fenugreek glycoside supplementation in male subjects during resistance training: A randomized controlled pilot study.

    Journal of sport and health science2016PMID 30356905Via: named in the paper, as read

  • Body composition and hormonal adaptations associated with forskolin consumption in overweight and obese men.

    Obesity research2005PMID 16129715Via: named in the paper, as read

Newest

  • Efficacy and Safety of TESTOPEAK™ in Improving Symptoms of Andropause in Korean Men: An 8-Week, Single-Center, Randomized, Parallel-Group, Placebo-Controlled Trial.

    American journal of men's health2026PMID 41923399As an endpoint

  • Effect of Eurycoma longifolia standardised aqueous root extract-Physta® on testosterone levels and quality of life in ageing male subjects: a randomised, double-blind, placebo-controlled multicentre study.

    Food & nutrition research2021PMID 34262417As an endpoint

  • Efficacy of Labisia pumila and Eurycoma longifolia standardised extracts on hot flushes, quality of life, hormone and lipid profile of peri-menopausal and menopausal women: a randomised, placebo-controlled study.

    Food & nutrition research2020PMID 33061884As an endpoint

  • Beneficial effects of fenugreek glycoside supplementation in male subjects during resistance training: A randomized controlled pilot study.

    Journal of sport and health science2016PMID 30356905As an endpoint

  • Body composition and hormonal adaptations associated with forskolin consumption in overweight and obese men.

    Obesity research2005PMID 16129715As an endpoint